Needle-Free Injection System Market Report | Share, Growth & Size 2028

[Research Report] The needle-free injection system market is expected to grow from US$ 131.64 million in 2021 to US$ 411.31 million by 2028; it is estimated to grow at a CAGR of 17.7% from 2022 to 2028.

Market Insights and Analyst View:

A needle-free injection system is a medical device that delivers medication or vaccines into the body without using a traditional needle. Instead of piercing the skin, the system uses high-pressure technology to force the medication through the skin and into the underlying tissue. This method is often preferred by patients who have a fear of needles and anxiety associated with injections. Needle-free injection systems are also used in situations where traditional needles may pose a risk of infection or injury. Needle-free injection devices use pressure to deliver medication through the skin, eliminating the need for a traditional needle. This can be more comfortable for patients and reduce the risk of needlestick injuries for the healthcare providers.

Factors that positively affect the needle-free injection system market are the growing demand for the prevalence of patients and the promotion of treatment across the globe, which boosts the need for needle-free injection systems. Also, there are rising technological advancements and increasing government initiatives for improving healthcare in the needle-free injection system market.   Despite the potential benefits of needle-free injection devices, some restraints may impact the market. One primary constraint is the cost associated with developing and manufacturing these devices. Needle-free injection technology can be more complex and expensive to produce compared to traditional needle-based methods, which may limit their accessibility for some patients and healthcare providers.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Needle-Free Injection System Market: Strategic Insights

Needle-Free Injection System Market

• 
  CAGR (2021 - 2028)

  17.7%
• Market Size 2021
  US$ 131.64 Million
• Market Size 2028
  US$ 411.31 Million

Market Dynamics

GROWTH DRIVERS

• Growing Prevalence of Patients and Promote Treatment to Boost Market Growth
• Research and Development Proficiencies

FUTURE TRENDS

• Strategic Activities by Manufacturers

OPPORTUNITIES

• Increasing Demand for Painless Drug Delivery

Key Players

• Crossject
• INOVIO Pharmaceuticals
• Zealand Pharma A S
• PharmaJet
• Portal Instruments
• Medical International Technologies MIT Canada Inc
• NuGen Medical Devices
• Ferring B V
• National Medical Products Inc

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Liquid-Based Needle-Free Injectors
• Projectile/Depot-Based Needle-Free Injectors
• Powder-Based Needle Free Injectors

Product

• Fillable Needle-Free Injectors
• Prefilled Needle-Free Injectors

Technology

• Jet-Based Needle-Free Injectors
• Spring Global Needle-Free Injectors
• Laser-Powered Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

Usability

• Disposable Needle-Free Injectors
• Reusable Needle-Free Injectors

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Growth Drivers:

One major driver for needle-free injection systems is improving patient comfort and compliance. Many patients, especially children and those with needle phobias, experience anxiety and fear when faced with traditional needle injections. By offering a needle-free alternative, healthcare providers can enhance users/patients satisfaction and adherence to treatment plans. Another driver is the potential for reducing the risk of needlestick injuries and associated contaminations among healthcare workers. Needlestick injuries can lead to serious health risks, including the transmission of bloodborne pathogens such as HIV and hepatitis. By eliminating the need for needles, needle-free injection systems can help protect healthcare workers from these occupational hazards.

Additionally, needle-free injection systems offer the potential for more precise and consistent drug delivery. The high-pressure technology in these systems can ensure that medications are delivered at the correct depth and with the right force, leading to improved treatment outcomes. Overall, the drive for needle-free injection systems is fueled by the desire to improve patient comfort, enhance safety for healthcare workers, and optimize the delivery of medications and vaccines. As technology advances, the development and adoption of needle-free injection systems are expected to grow in the healthcare industry.  

Opportunities:

The increasing demand for more convenient and less invasive drug delivery methods presents a significant opportunity for the needle-free injection market. Needle-free injection devices offer a painless and convenient alternative to traditional injections, making it easier for patients to adhere to their medication regimens. These devices use technologies such as jet injectors or microneedles to deliver medications without a needle, providing a more comfortable experience for patients. This can improve medication adherence and patient outcomes, especially for chronic conditions requiring frequent injections. In addition, needle-free injection devices can help reduce the chances of needlestick injuries and transmission of bloodborne infections, making them a safer option for patients and healthcare providers. As the demand for more convenient and effective drug delivery methods continues to grow, the needle-free injection market has the potential to expand and provides innovative solutions for meeting the needs of patients and healthcare providers. This presents a significant opportunity for operating companies in the healthcare industry to develop and commercialize needle-free injection devices that can positively impact patient care and treatment outcomes.

Report Segmentation and Scope:

The “Needle-Free Injection System Market” is segmented based on Type, Product, Technology, Usability, Site of Delivery, Application, End User, and geography. Based on type, the market is segmented into liquid-based needle-free injectors, projectile/depot-based needle-free injectors, powder-based needle free injectors. In terms of Product, the Needle-Free Injection System market is segmented into fillable needle-free injectors, prefilled needle-free injectors. Based on the technology, the market is categorized into jet-based needle-free injectors, spring global needle free injectors, laser-powered needle-free injectors, vibration-based needle-free injectors. Based on Usability, the market is segmented into disposable needle-free injectors, reusable needle-free injectors. Based on site of delivery, the market is segmented into subcutaneous injectors, intramuscular injectors, intradermal injectors. In terms of application, the needle-free injection system market is segmented into vaccine delivery, insulin delivery, oncology, pain management, other. Based on end user, the market is segmented into hospitals and clinics, home care settings, research laboratories, pharmaceutical and biotechnological companies, other. The Needle-Free Injection System market, based on geography is segmented into North America (US, Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (Australia, China, Japan, India, South Korea, and Rest of Asia Pacific), Middle East & Africa (South Africa, Saudi Arabia, UAE, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).     

Segmental Analysis:

Based on Type, the market is segmented into Liquid-Based Needle-Free Injectors, Projectile/Depot-Based Needle-Free Injectors and Powder-Based Needle Free Injectors. The Liquid-Based Needle-Free Injectors segment held the largest share of the market in 2022 and is estimated to register the highest CAGR in the market during 2022-2030. One major driver for the liquid-based needle-free injection market is the growing demand for more convenient and less painful drug delivery methods. Patients are increasingly seeking out alternatives to traditional needle injections, and liquid-based needle-free injection systems offer a more comfortable and less invasive option. Another driver is the potential for improved medication adherence and patient outcomes. Liquid-based needle-free injection systems can provide more precise and consistent drug delivery, improving treatment efficacy and patient satisfaction.

Additionally, the increasing incidence and prevalence of chronic diseases and the need for regular medication administration are driving the demand for more user-friendly injection methods. Liquid-based needle-free injection systems can help patients and healthcare providers manage chronic conditions more effectively. Furthermore, the focus on reducing healthcare costs and improving efficiency drives the adoption of liquid-based needle-free injection systems. These systems can aids minimize the risk of needlestick injuries and associated healthcare costs and reduce the need for disposable needles and syringes. Overall, the liquid-based needle-free injection market is driven by the desire for more convenient, safe, and effective drug dosage delivery methods, as well as the need to improves patient outcomes and reduce the healthcare costs. As a result, the market for these systems is expected to continue to grow in the coming years.

Regional Analysis:

Based on geography, the Needle-Free Injection System market is divided into five key regions: North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa. North America will likely capture a significant global Needle-Free Injection System market share in 2022. The market growth in the region is attributed to the growing demand for minimally invasive procedures, rising technological advancements, and Increasing focus on patient safety. The higher incidences and prevalence of chronic diseases, such as diabetes, hypertension, and asthma, has led to a greater need for regular medication administration. Many of these conditions require daily or frequent doses of medication to manage symptoms and prevent complications. As a result, there is a growing demand for drug delivery methods that are more convenient and less invasive, making it easier for patients to adhere to their prescribed treatment regimens. Traditional methods of drug dosage delivery, such as oral tablets or injections, can be cumbersome and painful for patients, leading to poor adherence and suboptimal treatment outcomes. As a result, there is a need for innovative drug delivery technologies that can provide a more convenient and comfortable experience for patients.

Additionally, the rise in chronic diseases has put a burden on healthcare systems and resources, leading to a focus on reducing healthcare costs and improving efficiency. By improving medication adherence and patient outcomes through more effective drug delivery methods, healthcare providers can potentially reduce the burden of various chronic diseases and lower overall healthcare costs. Overall, the increasing prevalence of chronic diseases and the need for regular medication administration has created a strong demand for more convenient, safe, and effective drug delivery methods, such as Needle-Free Injection System, that can improve patient adherence and outcomes. These are among the major factors increasing the usage of needle-free injection systems in North American countries, including the US, Canada, and Mexico.

Further, ~1.4 million diabetes cases are diagnosed each year in the US. According to the Centers for Disease Control and Prevention, in 2020, ~88 million adults had prediabetes, which is 34.5% of the US adult population. According to the Canadian Diabetes Association, in 2022, there is an increasing prevalence of diabetes in the country, with 11.7 million reported cases of diabetes or prediabetes. According to the same source, ~5.7 million Canadians are living with diagnosed diabetes. According to Statistics Canada, Canada has a low fertility rate, decreasing from 1.47 children per woman in 2019 to 1.40 children per woman in 2020.  According to the Canadian Institute for Health Information, in July 2022, ~2.4 million people were diagnosed with heart disease. It was the second major cause of death after cancer in Canada. Demand for minimally invasive procedures has increased remarkably over the past few years to reduce the burden associated with a wide range of chronic diseases.    

Needle-Free Injection System Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Industry Developments and Future Opportunities:

Various initiatives taken by major players operating in the global needle-free injection system market are listed below:

1. In November 2023, Micron Biomedical received funds to manufacture needle-free vaccines. The vaccine is painless to administer and works by applying the microarray technology to the skin and pressing a button for delivery.
2. In June 2022, NovaXS launched its patented ‘Telosis technology’ to administer a narrow stream of medication without a needle in 0.3 seconds for smarter health decisions.
3. In December 2022, Prejex Inc. announced an agreement with Polybond to manufacture needleless injections.
4. In November 2020, PharmaJet, a leading manufacturer of needle-free injection devices, announced a strategic partnership with Mundipharma, a global pharmaceutical company. This partnership aimed to expand the availability of PharmaJet's needle-free injection technology for administering vaccines and medications.

Competitive Landscape and Key Companies:

PharmaJet, Portal Instruments, Medical International Technology, Inc., NuGen Medical Devices, Crossject SA, Antares Pharma, 3M, Injex Pharma AG, NovaXS Biotech, INVIO Pharmaceutical Inc. are the major needle-free injection system companies. These companies focus on new technologies, advancements in existing products, and geographic expansions to meet the growing consumer demand worldwide.